Integrating preventive oral health with medical care
Our purpose is to improve the oral health of adults with Special Needs, Complex Needs and Geriatric Needs, using a painless, cost-effective treatment of oral dysbiosis (the primary cause of poor oral health). These high risk communities account for 4 in 10 adults.
Their unmet need for better oral health is amongst the largest in pharmaceuticals.
CHX is a pharmaceutical company developing and marketing a new treatment for oral dysbiosis – the primary cause of poor oral health.
Prevora is a high-strength, long-lasting antiseptic topically applied by the hygienist to the teeth of adults at high risk of poor oral health.
Better Outcomes, Lower Cost
Prevora is a profoundly new approach to oral healthcare. It deals with the cause not the consequence of poor oral health.
The Ontario Centre for Excellence and CHX co-fund Mount Sinai Hospital’s review of its Special Care dental program.
In this new age of containing medical costs, it seems the ultimate argument and purpose for oral health services is better overall health. For example, note this excerpt form a recent blog in Health Affairs, an influential journal in organizing the healthcare system: “Periodontal disease treatment can reduce medical costs in patients with diabetes, coronary artery disease, and cerebral vascular disease. Gum disease is strongly linked to poor cognitive brain function among patients with Alzheimer’s disease. The risk of developing dementia has been found to be higher in those with periodontitis than those without it.”Read More